ArticleGlycobiology2026
Defined O-acetylated Neu5Ac substrates reveal position-specific preferences of gut bacterial sialidases.
Article in Glycobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sialic acid on intestinal glycans is modified by O-acetylation, a modification that can protect glycans from bacterial degradation and modulate immune recognition. However, the specificity of gut bacterial sialidases toward O-acetylated sialic acid remains poorly defined. Here, we characterized six GH33 sialidases from Bacteroides spp. and Akkermansia muciniphila using chemically defined 4-methylumbelliferyl substrates bearing 4-O-, 7-O-, or 8/9-O-acetylated N-acetylneuraminic acid (Neu5Ac). All enzymes adopted the canonical β-propeller fold and displayed distinct substrate preferences. While 8/9-O-acetylated Neu5Ac was broadly tolerated and 7-O-acetylation variably accommodated, all commensal sialidases were unable to cleave 4-O-acetylated Neu5Ac. Endogenous murine caecal sialidase activity showed the same pattern. Removal of the 4-O-acetyl group by a viral sialate O-acetylesterase restored cleavage, demonstrating that the C4 acetyl group directly prevents hydrolysis. On primary colonic and splenic lymphocytes, the bacterial sialidases produced enzyme-, linkage-, cell-type-, and tissue-dependent changes in sialic acid-dependent lectin and Siglec-E-Fc binding. In colon tissue, however, only the broad-spectrum pathogen-derived NanI sialidase consistently reduced SNA, MAL2, and Siglec-E-Fc binding, while the commensal enzymes caused more restricted changes. These findings demonstrate pronounced position-dependent effects of Neu5Ac O-acetylation on the activity of the sialidases tested and reveal substantial enzyme-specific differences in the processing of defined O-acetylated substrates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.